World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
83
Citations
35549
World Ranking
958
National Ranking
87

Medicine

D-Index
86
Citations
36815
World Ranking
13913
National Ranking
1285

Overview

Paul T. Heath is affiliated with St George's, University of London in the United Kingdom and has contributed extensively to the field of Medicine, particularly focusing on Epidemiology, Infectious Diseases, Public Health, Microbiology, and related subfields.

The scientist's research covers key topics such as:

  • Neonatal and Maternal Infections
  • Pneumonia and Respiratory Infections
  • SARS-CoV-2 and COVID-19 Research
  • Bacterial Infections and Vaccines
  • Vaccine Coverage and Hesitancy
  • Streptococcal Infections and Treatments
  • COVID-19 Impact on Reproduction

Among their recent papers are the following:

  • Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK, 2020, The Lancet
  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial, 2020, The Lancet
  • Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection, 2021, Nature Medicine
  • Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial, 2021, The Lancet
  • Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial, 2021, The Lancet

Frequent co-authors collaborating with Paul T. Heath include:

  • Kirsty Le Doaré
  • Asma Khalil
  • Matthew D. Snape
  • Christine E. Jones
  • Saul N. Faust

The scientist regularly publishes in several journals, with multiple contributions to these venues:

  • Open Forum Infectious Diseases
  • The Pediatric Infectious Disease Journal
  • Vaccine
  • The Lancet
  • Journal of Infection

Best Publications

  • Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

    M Voysey;Clemens Sac.;S A Madhi;L Y Weckx

  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

    P M Folegatti;K J Ewer;P K Aley;B Angus

  • Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

    M Voysey;S A Costa Clemens;S A Madhi;L Y Weckx

  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

    Pedro M Folegatti;Katie J Ewer;Parvinder K Aley;Brian Angus

  • Neonatal sepsis: an international perspective

    S Vergnano;M Sharland;P Kazembe;C Mwansambo

  • Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis.

    Karen M Edmond;Christina Kortsalioudaki;Susana Scott;Stephanie J Schrag

  • Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.

    Katherine R W Emary;Tanya Golubchik;Parvinder K Aley;Cristina V Ariani

  • Neonatal infections in England: the NeonIN surveillance network

    Stefania Vergnano;Esse Menson;Nigel Kennea;Nick Embleton

  • Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.

    Paul T. Heath;Eva P. Galiza;David N. Baxter;Marta Boffito

  • Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children.

    Anna C. Seale;Fiorella Bianchi-Jassir;Neal J. Russell;Maya Kohli-Lynch

  • Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses.

    Jennifer Hall;Nadine Hack Adams;Linda Bartlett;Anna C Seale;Anna C Seale

  • Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.

    Xinxue Liu;Robert H Shaw;Arabella S V Stuart;Melanie Greenland

  • Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses.

    Lola Madrid;Lola Madrid;Anna C. Seale;Anna C. Seale;Maya Kohli-Lynch;Maya Kohli-Lynch;Karen M. Edmond

  • An overview of global GBS epidemiology.

    Kirsty Le Doare;Paul T. Heath

  • Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants

    Shabir A Madhi;Fernando P Polack;Pedro A Piedra;Flor M Munoz

  • COVID-19 Vaccination During Pregnancy: Coverage and Safety.

    Helena Blakeway;Smriti Prasad;Erkan Kalafat;Paul T. Heath

  • SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes.

    Asma Khalil;Asma Khalil;Erkan Kalafat;Erkan Kalafat;Can Benlioglu;Pat O'Brien;Pat O'Brien

  • X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management, and outcome of the disease

    Claire Booth;Kimberly C. Gilmour;Paul Veys;Andrew R. Gennery

  • Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

    Unknown

  • Group B streptococcal disease in UK and Irish infants younger than 90 days

    Paul T. Heath;Gail Balfour;Abbie M. Weisner;Androulla Efstratiou

  • Severe and unrecognised: pertussis in UK infants.

    N S Crowcroft;R Booy;T Harrison;L Spicer

  • Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine (preprint)

    Voysey, Merryn, Costa Clemens, Sue Ann, Madhi, Shabir A.;Weckx, Lily Yin, Folegatti, Pedro M.;Parvinder K. Aley;Angus, Brian John, Baillie, Vicky, Barnabas, Shaun L.

  • Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.1.7 Variant

    Seth Toback;Paul T. Heath;Eva P. Galiza;David Baxter

Frequent Co-Authors

Shamez N. Ladhani
Shamez N. Ladhani UK Health Security Agency
Andrew J. Pollard
Andrew J. Pollard University of Oxford
Mike Sharland
Mike Sharland St George's, University of London
Adam Finn
Adam Finn University of Bristol
Matthew D. Snape
Matthew D. Snape University of Oxford
Saul N. Faust
Saul N. Faust University Hospital Southampton NHS Foundation Trust
Shabir A. Madhi
Shabir A. Madhi University of the Witwatersrand
Mary Ramsay
Mary Ramsay UK Health Security Agency
Mary P. E. Slack
Mary P. E. Slack Griffith University
Asma Khalil
Asma Khalil St George's, University of London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to various allied health and science careers that can also be explored through online education. For those interested in healthcare administration, some of the fastest online medical billing and coding certificate programs offer a quick path to entering the medical billing sector, complementing microbiology knowledge with essential administrative skills.

If you are looking for advanced options, there are several medical degrees online that pay well. These programs allow microbiologists to pivot into clinical roles or healthcare management while benefiting from the flexibility of remote learning.

Additionally, those interested in public health can explore online MPH programs easy to get into. These degrees expand career options into epidemiology, health education, and global health initiatives, fields closely aligned with microbiology’s focus on disease and prevention.

Career pathways in child development and support services also intersect with microbiology through health science applications. For example, understanding health impacts can enhance roles such as a child life specialist. Exploring the child specialist salary and career requirements can provide valuable insights for microbiology graduates considering this pathway.

Best Scientists Citing Paul T. Heath

Trending Scientists

Recently Published Articles